Bristol-Myers Squibb Co - Company Profile
Powered by
All the data and insights you need on Bristol-Myers Squibb Co in one report.
- Save hours of research time and resources with
our up-to-date Bristol-Myers Squibb Co Strategy Report
- Understand Bristol-Myers Squibb Co position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View moreBristol-Myers Squibb Co (BMS) is a global biopharmaceutical company that carries out the discovery, development, licensing, manufacture, marketing, distribution and sale of pharmaceutical and other healthcare-related products. With its strong portfolio of oncology products, established market position and focused R&D activities, the company is in a secure and leading position in the pharmaceutical and healthcare market, even as a decline in the performance of Revlimid and significant dependence on a single territorial segment for revenue are causes for concern to BMS. Strategic acquisitions, approval of new products, and product pipeline could provide it growth opportunities. However, reliance on distributors, government regulations and operational risks of product and industry could affect the financial condition of the company.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward